CBAY logo

CymaBay Therapeutics (CBAY) Total Liabilities

Annual Total Liabilities

$142.43 M
+$36.73 M+34.75%

31 December 2023

CBAY Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Liabilities

$142.43 M
+$17.57 M+14.07%

31 December 2023

CBAY Quarterly Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CBAY Total Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+34.8%+14.1%
3 y3 years+1181.0%+297.4%
5 y5 years+772.3%+641.5%

CBAY Total Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years
5 y5 years
alltimeall time-57.7%at high

CymaBay Therapeutics Total Liabilities History

DateAnnualQuarterly
Dec 2023
$142.43 M(+34.8%)
$142.43 M(+14.1%)
Sept 2023
-
$124.86 M(+5.6%)
June 2023
-
$118.24 M(-16.2%)
Mar 2023
-
$141.13 M(+33.5%)
Dec 2022
$105.70 M(+52.3%)
$105.70 M(+6.7%)
Sept 2022
-
$99.07 M(+4.0%)
June 2022
-
$95.27 M(+2.2%)
Mar 2022
-
$93.26 M(+34.4%)
Dec 2021
$69.38 M(+524.0%)
$69.38 M(+93.6%)
Sept 2021
-
$35.84 M(+260.3%)
June 2021
-
$9.95 M(+10.1%)
Mar 2021
-
$9.04 M(-18.7%)
Dec 2020
$11.12 M(-42.6%)
$11.12 M(-6.2%)
Sept 2020
-
$11.85 M(+7.8%)
June 2020
-
$10.99 M(-18.9%)
Mar 2020
-
$13.55 M(-30.1%)
Dec 2019
$19.38 M(+18.7%)
$19.38 M(+0.9%)
Sept 2019
-
$19.21 M(+10.5%)
June 2019
-
$17.38 M(+5.1%)
Mar 2019
-
$16.53 M(+1.2%)
Dec 2018
$16.33 M
$16.33 M(+4.8%)
DateAnnualQuarterly
Sept 2018
-
$15.58 M(-17.8%)
June 2018
-
$18.95 M(-5.5%)
Mar 2018
-
$20.06 M(+3.9%)
Dec 2017
$19.30 M(+25.1%)
$19.30 M(+8.2%)
Sept 2017
-
$17.84 M(+7.5%)
June 2017
-
$16.59 M(+2.7%)
Mar 2017
-
$16.15 M(+4.7%)
Dec 2016
$15.42 M(+3.1%)
$15.42 M(+5.8%)
Sept 2016
-
$14.57 M(-3.2%)
June 2016
-
$15.05 M(+0.9%)
Mar 2016
-
$14.92 M(-0.3%)
Dec 2015
$14.96 M(-36.7%)
$14.96 M(-2.6%)
Sept 2015
-
$15.37 M(+39.8%)
June 2015
-
$10.99 M(-33.2%)
Mar 2015
-
$16.46 M(-30.3%)
Dec 2014
$23.62 M(+69.9%)
$23.62 M(+27.6%)
Sept 2014
-
$18.52 M(+5.5%)
June 2014
-
$17.56 M(-11.4%)
Mar 2014
-
$19.82 M(+42.5%)
Dec 2013
$13.90 M(-95.9%)
$13.90 M
Dec 2012
$336.68 M
-

FAQ

  • What is CymaBay Therapeutics annual total liabilities?
  • What is the all time high annual total liabilities for CymaBay Therapeutics?
  • What is CymaBay Therapeutics annual total liabilities year-on-year change?
  • What is CymaBay Therapeutics quarterly total liabilities?
  • What is the all time high quarterly total liabilities for CymaBay Therapeutics?
  • What is CymaBay Therapeutics quarterly total liabilities year-on-year change?

What is CymaBay Therapeutics annual total liabilities?

The current annual total liabilities of CBAY is $142.43 M

What is the all time high annual total liabilities for CymaBay Therapeutics?

CymaBay Therapeutics all-time high annual total liabilities is $336.68 M

What is CymaBay Therapeutics annual total liabilities year-on-year change?

Over the past year, CBAY annual total liabilities has changed by +$36.73 M (+34.75%)

What is CymaBay Therapeutics quarterly total liabilities?

The current quarterly total liabilities of CBAY is $142.43 M

What is the all time high quarterly total liabilities for CymaBay Therapeutics?

CymaBay Therapeutics all-time high quarterly total liabilities is $142.43 M

What is CymaBay Therapeutics quarterly total liabilities year-on-year change?

Over the past year, CBAY quarterly total liabilities has changed by +$17.57 M (+14.07%)